Genetic Variation Linked to Dosing Differences for Transplant Medication in Children
A new study reveals that specific genetic variations significantly influence how pediatric heart transplant patients process the vital immunosuppressant drug tacrolimus.
❤️Conditions & CarePhoto: Nature Health Sciences
Key points
- Children with the CYP3A5*1 allele required a 2.7-fold higher dose of tacrolimus.
- Metabolite concentrations were lower in patients carrying the CYP3A5*1 allele.
- Larger studies are needed to establish routine genetic-guided dosing protocols.
Researchers investigating the pharmacokinetics of tacrolimus in pediatric heart transplant recipients have found that genetic differences in the CYP3A5 enzyme heavily affect medication requirements. Published in Nature Health Sciences, the study analyzed saliva and whole blood samples from 64 children who had undergone heart transplantation to better understand why patients process the anti-rejection drug at varying rates.
The findings indicate that young patients carrying the CYP3A5*1 allele required a 2.7-fold higher dose of tacrolimus compared to those with the CYP3A5*3/*3 genotype. Furthermore, weight-adjusted dose-normalized concentrations of both the parent medication and its M-I and M-II metabolites were notably lower among children possessing the CYP3A5*1 allele. Tacrolimus remains a primary immunosuppressive agent used to prevent organ rejection after solid organ transplantation, but it is known for a narrow therapeutic window and substantial variability between patients.
While the study demonstrates a clear link between the CYP3A5 genotype and drug pharmacokinetics, the authors emphasize that larger studies are necessary to confirm its ultimate clinical importance. Because the research relied on an observational cohort of 64 pediatric patients and genetic-guided dosing is not yet widely implemented in routine clinical practice, these findings highlight early-stage evidence rather than an immediate change in medical guidelines. Pediatric patients possess unique physiological factors, such as age-based maturation and fluid load shifts, that separate them from adult or kidney and liver transplant populations.
What to know: Children with the CYP3A5*1 genetic variant needed higher doses of the anti-rejection drug tacrolimus, suggesting that future dosing strategies might benefit from genetic profiling. Always consult a qualified healthcare provider regarding personal medical decisions and treatment plans.
Source Nature Health Sciences — nature.com/articles/s41397-026-00435-z ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
🧠AI AnalysisUltraprocessed Diets May Impact Brain Reward Systems in Younger Adults
A Virginia Tech study suggests that individuals aged 18 to 21 may experience changes in brain reward processing after consuming ultraprocessed foods, a response not obser…
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
🔬ResearchCBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities
A double-blind clinical trial published in JAMA Pediatrics indicates that CBD oil provides no significant behavioral improvement for children and teenagers with intellect…